Evans-Freke
Stephen Evans-Freke, St. Thomas, VI US
Patent application number | Description | Published |
---|---|---|
20100113341 | METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER - Provided herein is a method for treating cancer in a human by administering a high dose of corticotropin-releasing factor (CRF) for a period of time exceeding 3 days. | 05-06-2010 |
20100196389 | METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE USE OF THE TREATMENT OF CANCER - Provided herein is a method for treating cancer in a human by administering a high dose of corticotropin-releasing factor (CRF). | 08-05-2010 |
20100203048 | METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE USE OF THE TREATMENT OF CANCER - Provided herein is a method for treating cancer in a human by administering a high dose of corticotropin-releasing factor (CRF). | 08-12-2010 |
20120183536 | METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER - Provided herein is are methods of treating cancer in a human by administering CRF, optionally in combination with a second agent, such as an angiogenesis inhibitor. | 07-19-2012 |
Stephen Evans-Freke, Tuxedo Park, NY US
Patent application number | Description | Published |
---|---|---|
20100183594 | STEROID-SPARING METHODS OF TREATING BRAIN EDEMA - The present invention relates to therapeutic regimens or protocols designed for the treatment, management or prevention of edema. In particular, the invention pertains to methods of treating or managing edema associated with brain tumors involving the administration of a therapeutically effective amount of corticorelin acetate that achieves a steroid-sparing effect. | 07-22-2010 |
Stephen Evans-Freke, St. Thomas VG
Patent application number | Description | Published |
---|---|---|
20120077744 | STEROID-SPARING METHODS OF TREATING BRAIN EDEMA - The present invention relates to therapeutic regimens or protocols designed for the treatment, management or prevention of edema. In particular, the invention pertains to methods of treating or managing edema associated with brain tumors involving the administration of a therapeutically effective amount of corticorelin acetate that achieves a steroid-sparing effect. | 03-29-2012 |